Your browser doesn't support javascript.
loading
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.
Meng, Juan; Xiao, Guohui; Zhang, Juanjuan; He, Xing; Ou, Min; Bi, Jing; Yang, Rongqing; Di, Wencheng; Wang, Zhaoqin; Li, Zigang; Gao, Hong; Liu, Lei; Zhang, Guoliang.
Afiliação
  • Meng J; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Xiao G; Shenzhen Bay Laboratory, Shenzhen, People's Republic of China.
  • Zhang J; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • He X; Shenzhen Bay Laboratory, Shenzhen, People's Republic of China.
  • Ou M; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Bi J; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Yang R; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Di W; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Wang Z; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Li Z; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Gao H; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Liu L; Shenzhen Bay Laboratory, Shenzhen, People's Republic of China.
  • Zhang G; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Emerg Microbes Infect ; 9(1): 757-760, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32228222
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Sistema Renina-Angiotensina / Inibidores da Enzima Conversora de Angiotensina / Infecções por Coronavirus / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Hipertensão / Anti-Hipertensivos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Sistema Renina-Angiotensina / Inibidores da Enzima Conversora de Angiotensina / Infecções por Coronavirus / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Hipertensão / Anti-Hipertensivos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article